Sznol, M., Fishman, M., Escudier, B., McDermott, D. F., Kluger, H., Stadler, W. M., Perez-Gracia, J., McNeel, D. G., Curti, B. D., Harrison, M. R., Plimack, E. R., Appleman, L., Fong, L., Drake, C. G., Young, T. C., Chasalow, S. D., Ross-MacDonald, P., Simon, J. S., Walker, D., & Choueiri, T. K. (n.d.). markers of inflammation are associated with clinical outcomes in patients with metastatic renal cell carcinoma treated with nivolumab. Journal for immunotherapy of cancer, 3, . http://access.bl.uk/ark:/81055/vdc_100137792898.0x000001